NCT00050934

Pediatric Epilepsy Study

A Multicenter, Rater-blind, Randomized, Age-stratified, Parallel-group Study Comparing Two Doses of Oxcarbazepine as Adjunctive Therapy in Pediatric Patients With Inadequately-controlled Partial Seizures.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 132 (actual)
• Sponsor: Novartis Pharmaceuticals · Industry
• Sex: All
• Age: 1 Month – 3 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the safety and effectiveness of oxcarbazepine (Trileptal) as add-on therapy in the treatment of partial seizures in pediatric patients 1 month to 3 years of age.

Conditions

• Epilepsy
• Epilepsies, Partial

Interventions

Type	Name	Description
DRUG	oxcarbazepine

Timeline

• Start date: 2002-06-01
• Primary completion: 2004-06-01
• Completion: 2004-06-01
• First posted: 2003-01-01
• Last updated: 2011-11-23

Locations

30 sites across 4 countries: United States, Brazil, Germany, Mexico